Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a human growth hormone presented as a sterile solution for subcutaneous use. It is prescribed for growth hormone deficiency in children and adults, as well as for specific genetic and renal conditions that affect growth.

GNH USA supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides cold‑chain logistics for biologic products, ensuring product integrity from manufacture to delivery.

Norditropin Flexpro, a recombinant human growth hormone, is used to address disorders of growth hormone deficiency and related syndromes. - Growth hormone deficiency in children: promotes linear growth and improves height velocity. - Growth hormone deficiency in adults: enhances body composition, reduces adiposity, and improves quality of life. - Turner syndrome: supports increased stature and bone health in affected females. - Prader‑Willi syndrome: aids in improving body composition and growth parameters. - Chronic renal insufficiency: helps mitigate growth retardation associated with renal disease.

Norditropin Flexpro may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Injection site pain: mild discomfort or redness at the injection site. - Headache: transient headache episodes. - Joint stiffness: occasional stiffness in joints. - Edema: mild swelling of extremities.

Serious or Rare Side Effects: - Intracranial hypertension: signs of increased intracranial pressure such as headache, vomiting, visual changes. - Glucose intolerance: elevated blood glucose or new‑onset diabetes. - Allergic reaction: rash, urticaria, or anaphylaxis.

When using Norditropin Flexpro, consider the following precautions. - Dose titration: adjust dose based on IGF‑1 levels and clinical response. - Monitoring: regularly assess growth parameters, glucose, and thyroid function. - Contraindication: avoid in patients with active malignancy. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Long‑term therapy: monitor for signs of slipped epiphyses in children. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norditropin Flexpro can interact with several medicines.

Major Interactions (Avoid): - Glucocorticoids: high doses may antagonize growth hormone effects. - Insulin or oral hypoglycemics: may require dose adjustment due to altered glucose metabolism. - Estrogen therapy: can increase IGF‑1 levels, necessitating monitoring.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: growth hormone can increase thyroid hormone requirements. - Cytochrome P450 inducers: may affect hormone metabolism, though effect is minimal. - Oral contraceptives: may modify IGF‑1 response.